Evolving Therapeutic Paradigms and Biomarker-Driven Prognostication in Guillain-Barré Syndrome: A Comprehensive Multicenter Evaluation
Serum neurofilament light chain serves as a robust biomarker for axonal damage and functional prognosis in GBS, and integrating sNfL quantification with standard clinical grading scales enhances risk stratification and personalized therapeutic management.
M. Moinudeen, Shree R. Singh, Nidhi Singh
· 0 citations